Version 1
: Received: 28 July 2023 / Approved: 31 July 2023 / Online: 31 July 2023 (11:40:48 CEST)
Version 2
: Received: 29 August 2023 / Approved: 30 August 2023 / Online: 30 August 2023 (07:30:36 CEST)
How to cite:
Kelleni, M. Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol. Preprints2023, 2023072079. https://doi.org/10.20944/preprints202307.2079.v2
Kelleni, M. Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol. Preprints 2023, 2023072079. https://doi.org/10.20944/preprints202307.2079.v2
Kelleni, M. Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol. Preprints2023, 2023072079. https://doi.org/10.20944/preprints202307.2079.v2
APA Style
Kelleni, M. (2023). Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol. Preprints. https://doi.org/10.20944/preprints202307.2079.v2
Chicago/Turabian Style
Kelleni, M. 2023 "Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol" Preprints. https://doi.org/10.20944/preprints202307.2079.v2
Abstract
The current recommendation to avoid non-steroidal anti-inflammatory drugs (NSAIDs) in management of dengue virus disease is, as it was adopted earlier in COVID-19, scientifically considered of very low to low certainty. In this perspective I argue, for the first time globally, basing on real-life practice that NSAIDs might be lifesaving in early management of dengue virus disease as I originally argued and proved rightful in COVID-19. Moreover, I also argue that the Egyptian immune-modulatory Kelleni’s protocol, including nitazoxanide as an integral component, can be safely and effectively used to early manage COVID-19, human metapneumovirus, dengue virus disease, Zika virus separate or co-infections similar to what has already been experienced and published with separate or conjoined infections with SARS CoV-2, influenza, RSV and Norwalk viruses without the need of prior serological or molecular investigations to determine the causative agent.
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received:
30 August 2023
Commenter:
Mina Kelleni
Commenter's Conflict of Interests:
Author
Comment:
The original version has been revised; some typos were corrected, additional discussion and references were added to include the current and potential viruses that are and could be managed using Kelleni's protocol and a figure was also inserted.
Commenter: Mina Kelleni
Commenter's Conflict of Interests: Author